Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The preservation of muscle mass and muscle function after weight loss therapy is currently a considerable challenge in the fight against obesity. Muscle mass secretes proteins called myokines that have relevant functions in the regulation of metabolism and health. This study was aimed to evaluate whether a very low-calorie ketogenic (VLCK) diet may modulate myokine levels, in addition to changes in body composition, compared to a standard, balanced low-calorie (LC) diet or bariatric surgery in patients with obesity. Body composition, ketosis, insulin sensitivity and myokines were evaluated in 79 patients with overweight/obesity after a therapy to lose weight with a VLCK diet, a LC diet or bariatric surgery. The follow-up was 6 months. The weight loss therapies induced changes in myokine levels in association with changes in body composition and biochemical parameters. The effects on circulating myokine levels compared to those at baseline were stronger after the VLCK diet than LC diet or bariatric surgery. Differences reached statistical significance for IL-8, MMP2 and irisin. In conclusion, nutritional interventions or bariatric surgery to lose weight induces changes in circulating myokine levels, being this effect potentially most notable after following a VLCK diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Self-citationMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 6×
“IL-6 is the most widely studied exercise-regulated cytokine [13] and is associated with obesity and insulin resistance [13]; but it is also highly produced and secreted after exercise, enhancing insulin action and other metabolic processes [12].”
BackgroundInfluentialPharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
The science of obesity management: an endocrine society scientific statement
Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00253 · Cited by 812
Pedersen, B. K. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.048074 · Cited by 668
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621
FNDC5/irisin is not only a myokine but also an adipokine
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Crujeiras, A. B., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060563 · Cited by 612 · cited 1×
“Considering that no evident changes in fat-free mass were observed in these patients, and that irisin is also an adipokine [43], fat mass was considered the main factor explaining the increase in circulating irisin levels [20].”
BackgroundPreserving Healthy Muscle during Weight Loss
Cava, E., Yeat, N. C., & Mittendorfer, B. (2017) · Advances in Nutrition · doi:10.3945/an.116.014506 · Cited by 452 · cited 5×
“Diet-induced weight loss is used as treatment for obesity; however, the main problem of these diets is that high amount of fat-free mass—mainly skeletal muscle mass [5]—is also lost together with the fat mass [4,6]; this may increase the risk of sarcopenic obesity [4,6,7].”
BackgroundInfluential
Cited by
Ketone bodies: from enemy to friend and guardian angel
Kolb, H., Kempf, K., Röhling, M., Lenzen-Schulte, M., Schloot, N. C., & Martin, S. (2021) · BMC Medicine · doi:10.1186/s12916-021-02185-0 · Cited by 361
Muscogiuri, G., El Ghoch, M., Colao, A., Hassapidou, M., Yumuk, V., Busetto, L., & Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) (2021) · Obesity Facts · doi:10.1159/000515381 · Cited by 289
Yuan, X., Wang, J., Yang, S., Gao, M., Cao, L., Li, X., Hong, D., Tian, S., & Sun, C. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-00142-z · Cited by 240
Nuijten, M. A. H., Eijsvogels, T. M. H., Monpellier, V. M., Janssen, I. M. C., Hazebroek, E. J., & Hopman, M. T. E. (2022) · Obesity Reviews · doi:10.1111/obr.13370 · Cited by 236
Haghighat, N., Ashtary-Larky, D., Bagheri, R., Aghakhani, L., Asbaghi, O., Amini, M., Moeinvaziri, N., Hosseini, B., Wong, A., Shamekhi, Z., et al. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.02.022 · Cited by 36
Schiavo, L., Santella, B., Mingo, M., Rossetti, G., Orio, M., Cobellis, L., Maurano, A., Iannelli, A., & Pilone, V. (2025) · Nutrients · doi:10.3390/nu17071216 · Cited by 22
“…be positively modulated by ketogenic diets and may contribute to the preservation of FFM and metabolic flexibility during WL in individuals with obesity [52] The SURMOUNT clinical trial program (SURMOUNT-1, 2, 3, and 4) represents the most extensive evaluation of TZP in obesity management [14–17].”
Binmahfoz, A., Johnston, L., Dunning, E., Gray, C. M., & Gray, S. R. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00986-1 · Cited by 8
“This is important as skeletal muscle has both functional and metabolic roles [10], with low muscle mass/strength recognised as a contributing factor to cardiometabolic and other obesity-related diseases [11] and as being associated with higher mortality and morbidity [7].”
Metadata
- Authors
- Sajoux, I., Lorenzo, P. M., Gomez-Arbelaez, D., Zulet, M. A., Abete, I., Castro, A. I., Baltar, J., Portillo, M. P., Tinahones, F. J., Martinez, J. A., Crujeiras, A. B., & Casanueva, F. F.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-10-04
- Volume
- 11
- Issue
- 10
- Pages
- 2368
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2978102446
- Cited by
- 63
- References
- 20
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.